4-Antigen EBV Vaccine / Citranvi Biosci - LARVOL DELTA

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. (PubMed, Front Immunol) - "Therapeutic EBV vaccines have also been tested clinically with encouraging results...Adoptive T-cell therapy has been successfully used in the prevention and treatment of post-transplant lymphoproliferative disorder. Chimeric antigen receptor T cell therapy and T cell receptor engineered T cell therapy targeting EBV latent proteins LMP1, LMP2 and/or EBNA1 have been in development, with the goal to increase the specificity and efficacy of treatment of EBV associated cancers."

Journal • Review • CNS Disorders • Epstein-Barr Virus Infections • Infectious Disease • Multiple Sclerosis • Oncology • Transplantation • CD4 • CD8